{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:51:26Z","timestamp":1772736686712,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ijpharm.2011.04.055","type":"journal-article","created":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T01:56:26Z","timestamp":1304214986000},"page":"16-27","source":"Crossref","is-referenced-by-count":43,"title":["Use of remote film loading methodology to entrap sirolimus into liposomes: Preparation, characterization and in vivo efficacy for treatment of restenosis"],"prefix":"10.1016","volume":"414","author":[{"given":"Azadeh","family":"Haeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam Sotoudeh","family":"Anvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Boroumand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Dadashzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2011.04.055_bib0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.addr.2006.01.016","article-title":"Mechanisms of controlled drug release from drug-eluting stents","volume":"58","author":"Acharya","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jacc.2005.09.045","article-title":"Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer?","volume":"47","author":"Azarbal","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.biomaterials.2004.02.040","article-title":"Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries","volume":"26","author":"Banai","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0020","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jpba.2005.09.011","article-title":"Experimental design for in vitro skin penetration study of liposomal superoxide dismutase","volume":"40","author":"Braun","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.addr.2006.02.001","article-title":"Drug-eluting stents: an innovative multidisciplinary drug delivery platform","volume":"58","author":"Burt","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-3659(00)00240-6","article-title":"Influence of cholesterol on liposome fluidity by EPR. Relationship with percutaneous absorption","volume":"68","author":"Coderch","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0035","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1540-8183.2006.00198.x","article-title":"Polymers, drug release, and drug-eluting stents","volume":"19","author":"Commandeur","year":"2006","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0040","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.CIR.0000163587.36485.A7","article-title":"Molecular basis of restenosis and drug-eluting stents","volume":"111","author":"Costa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.colsurfb.2004.12.020","article-title":"Factors affecting protein release from microcapsule prepared by liposome in alginate","volume":"42","author":"Dai","year":"2005","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0050","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jps.10021","article-title":"A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling","volume":"91","author":"Desai","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0055","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0031-6997(24)01426-1","article-title":"Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors","volume":"51","author":"Drummond","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0060","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1002\/jps.21358","article-title":"Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development","volume":"97","author":"Drummond","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2005.11.006","article-title":"Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation","volume":"308","author":"El-Samaligy","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.104.508937","article-title":"Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents","volume":"112","author":"Finn","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0075","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1161\/01.CIR.99.16.2164","article-title":"Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle","volume":"99","author":"Gallo","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1503\/cmaj.081907","article-title":"Are drug-eluting stents safe in the long term?","volume":"180","author":"Genereux","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijpharm.2007.01.024","article-title":"Application of statistical experimental design to study the formulation variables influencing the coating process of lidocaine liposomes","volume":"337","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0090","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejpb.2007.04.003","article-title":"Preparation and characterization of radioactive dirhenium decacarbonyl-loaded PLLA nanoparticles for radionuclide intra-tumoral therapy","volume":"67","author":"Hamoudeh","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0005-2736(85)90521-8","article-title":"Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential","volume":"812","author":"Hope","year":"1985","journal-title":"Biochim. Biophys. Acta (BBA): Biomembr."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.addr.2006.01.013","article-title":"Drug-eluting stents: beyond the hyperbole","volume":"58","author":"Hunter","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-3659(03)00271-2","article-title":"Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel","volume":"91","author":"Immordino","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0110","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0115","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1211\/0022357011778016","article-title":"Effects of cholesterol and model transmembrane proteins on drug partitioning into lipid bilayers as analysed by immobilized-liposome chromatography","volume":"53","author":"Lagerquist","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0120","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/path.1598","article-title":"Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system","volume":"203","author":"Lee","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0731-7085(97)00173-8","article-title":"A computer-based expert system designs and analyzes a 2(k\u2212p) fractional factorial design for the formulation optimization of novel multicomponent liposomes","volume":"17","author":"Loukas","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0130","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications","volume":"115","author":"Luscher","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.RES.76.3.412","article-title":"Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells","volume":"76","author":"Marx","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0140","first-page":"365","article-title":"Coronary bifurcation stenting. Current techniques, outcome and possible future developments","volume":"52","author":"Melikian","year":"2004","journal-title":"Minerva Cardioangiol."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/hrt.2005.066993","article-title":"Drug-eluting stents: a critique","volume":"94","author":"Melikian","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1389557023405873","article-title":"Liposomes for intravenous drug targeting: design and applications","volume":"2","author":"Metselaar","year":"2002","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0155","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1208\/s12249-008-9097-x","article-title":"Conventional and dense gas techniques for the production of liposomes: a review","volume":"9","author":"Meure","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-5173(99)00222-7","article-title":"Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives","volume":"188","author":"Moribe","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0165","first-page":"144","article-title":"A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies","volume":"60","author":"Nallamothu","year":"2006","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jacc.2005.07.071","article-title":"Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project","volume":"47","author":"Nebeker","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0175","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2005.02.086","article-title":"Late angiographic stent thrombosis (LAST) events with drug-eluting stents","volume":"45","author":"Ong","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0180","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1172\/JCI119038","article-title":"Rapamycin inhibits vascular smooth muscle cell migration","volume":"98","author":"Poon","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0185","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/01.CIR.84.3.1426","article-title":"Clinical trials of restenosis after coronary angioplasty","volume":"84","author":"Popma","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1423-0127-17-57","article-title":"Development of a liposomal nanodelivery system for nevirapine","volume":"17","author":"Ramana","year":"2010","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCINTERVENTIONS.108.830018","article-title":"Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured artery","volume":"1","author":"Reddy","year":"2008","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0168-3659(87)90034-4","article-title":"A simple equation for description of solute release. I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0006-3495(95)80171-2","article-title":"Behavior of cholesterol and its effect on head group and chain conformations in lipid bilayers: a molecular dynamics study","volume":"68","author":"Robinson","year":"1995","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0210","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3109\/08982100902963043","article-title":"Development and characterization of liposomal formulations for rapamycin delivery and investigation of their antiproliferative effect on MCF7 cells","volume":"19","author":"Rouf","year":"2009","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0215","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jconrel.2005.08.023","article-title":"Liposomalization of SN-38 as active metabolite of CPT-11","volume":"108","author":"Sadzuka","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cpcardiol.2005.09.002","article-title":"Drug-eluting coronary stents","volume":"31","author":"Salam","year":"2006","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0225","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","article-title":"Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis","volume":"110","author":"Scheller","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0230","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/bi950414i","article-title":"Influence of cholesterol on the association of plasma proteins with liposomes","volume":"35","author":"Semple","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0235","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1023\/A:1018994111594","article-title":"Novel taxol formulations: preparation and characterization of taxol-containing liposomes","volume":"11","author":"Sharma","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0240","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00059-007-3000-5","article-title":"Biological effects of drug-eluting stents in the coronary circulation","volume":"32","author":"Steffel","year":"2007","journal-title":"Herz"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0245","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/clc.20177","article-title":"Present status of coronary bifurcation stenting","volume":"31","author":"Sukhija","year":"2008","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-59745-571-8_1","article-title":"Rat carotid artery balloon injury model","volume":"139","author":"Tulis","year":"2007","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/03639040701385055","article-title":"Preparation, optimization, and characterization of topotecan loaded PEGylated liposomes using factorial design","volume":"34","author":"Vali","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0260","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.94.7.1690","article-title":"Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries","volume":"94","author":"van der Giessen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejpb.2006.10.007","article-title":"In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine","volume":"65","author":"Webb","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0270","doi-asserted-by":"crossref","first-page":"392","DOI":"10.7326\/0003-4819-143-5-200509060-00119","article-title":"Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent","volume":"143","author":"Wessely","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0275","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/S0006-3495(98)77711-2","article-title":"Influence of chain ordering on the selectivity of dipalmitoylphosphatidylcholine bilayer membranes for permeant size and shape","volume":"75","author":"Xiang","year":"1998","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0280","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijpharm.2008.12.031","article-title":"Development of nobiliside A loaded liposomal formulation using response surface methodology","volume":"371","author":"Xiong","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0285","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejpb.2004.06.009","article-title":"Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation","volume":"59","author":"Zhang","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0290","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2003.10.015","article-title":"Development and characterization of a novel liposome-based formulation of SN-38","volume":"270","author":"Zhang","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.055_bib0295","series-title":"Liposomes, a practical approach","first-page":"31","article-title":"Characterization of liposomes","author":"Zuidam","year":"2003"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311003826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311003826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T09:41:04Z","timestamp":1741167664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517311003826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":59,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0378517311003826"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.04.055","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}